Chronic hepatitis B (CHB) is prevalent worldwide. The infectious agent, hepatitis B virus (HBV), replicates via an RNA intermediate and is error prone, leading to the rapid generation of closely related but not identical viral variants, including those that can escape host immune responses and antiviral treatments. The complexity of CHB can be further enhanced by the presence of HBV variants with large deletions in the genome generated via splicing (spHBV variants). Although spHBV variants are incapable of autonomous replication, their replication is rescued by wild-type HBV. spHBV variants have been shown to enhance wildtype virus replication, and their prevalence increases with liver disease progression. Single-molecule deep sequencing was performed on whole HBV genomes extracted from samples, including the liver explant, longitudinally collected from a subject with CHB over a 15-year period after liver transplantation. By employing novel bioinformatics methods, this analysis showed that the dynamics of the viral population across a period of changing treatment regimens was complex. The spHBV variants detected in the liver explant remained present posttransplantation, and a highly diverse novel spHBV population as well as variants with multiple deletions in the pre-S genes emerged. The identification of novel mutations outside the HBV reverse transcriptase gene that co-occurred with known drug resistance-associated mutations highlights the relevance of using full-genome deep sequencing and supports the hypothesis that drug resistance involves interactions across the full length of the HBV genome.
IMPORTANCESingle-molecule sequencing allowed the characterization, in unprecedented detail, of the evolution of HBV populations and offered unique insights into the dynamics of defective and spHBV variants following liver transplantation and complex treatment regimens. This analysis also showed the rapid adaptation of HBV populations to treatment regimens with evolving drug resistance phenotypes and evidence of purifying selection across the whole genome. Finally, the new open-source bioinformatics tools with the capacity to easily identify potential spliced variants from deep sequencing data are freely available.
H epatitis B virus (HBV) causes a widely prevalent chronic viral infection and infects 240 million people worldwide (1).Chronic hepatitis B (CHB) can lead to cirrhosis, liver failure, and hepatocellular carcinoma (HCC) (1, 2). HBV is a member of the Hepadnaviridae family and has a partially double-stranded relaxed circular DNA genome (3). The approximately 3,200-nucleotide (nt) genome consists of four overlapping, frame-shifted open reading frames (ORF) encoding the polymerase (P), envelope (ENV), X, and core (C) proteins. HBV can be divided into nine genotypes, labeled genotypes A to I, with a further putative genotype (genotype J) being proposed (4). With the exception of genotypes E and G, all genotypes can be further classified into subgenotypes. HBV genotypes differ in diversity by more than 8%,...